Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L G T Morris

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Oncogene|April 27, 2010
Genetic determinants at the interface of cancer and neurodegenerative diseaseL G T Morris, S Veeriah, T A Chan
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 27, 2017
Selective use of radioactive iodine (RAI) in thyroid cancer: No longer "one size fits all"J L Marti, L G T Morris, A S Ho
The Journal of Laryngology and Otology|March 20, 2010
Techniques for early diagnosis and management of cervicofacial necrotising fasciitisJ W Lee, S B Immerman, L G T Morris
The Journal of Laryngology and Otology|June 25, 2010
Lymph node central necrosis on computed tomography as predictor of extracapsular spread in metastatic head and neck squamous cell carcinoma: pilot studyR A Zoumalan, A J Kleinberger, L G T Morris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 2, 2022
Leveraging big data of immune checkpoint blockade response identifies novel potential targetsY Bareche, D Kelly, F Abbas-Aghababazadeh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2016
A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinomaA L Ho, L Dunn, E J Sherman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 17, 2024
Tumor and blood B-cell abundance outperforms established immune checkpoint blockade response prediction signatures in head and neck cancerT-G Chang, A Spathis, A A Schäffer, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Oncogene|April 27, 2010
Genetic determinants at the interface of cancer and neurodegenerative diseaseL G T Morris, S Veeriah, T A Chan
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 27, 2017
Selective use of radioactive iodine (RAI) in thyroid cancer: No longer "one size fits all"J L Marti, L G T Morris, A S Ho
The Journal of Laryngology and Otology|March 20, 2010
Techniques for early diagnosis and management of cervicofacial necrotising fasciitisJ W Lee, S B Immerman, L G T Morris
The Journal of Laryngology and Otology|June 25, 2010
Lymph node central necrosis on computed tomography as predictor of extracapsular spread in metastatic head and neck squamous cell carcinoma: pilot studyR A Zoumalan, A J Kleinberger, L G T Morris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 2, 2022
Leveraging big data of immune checkpoint blockade response identifies novel potential targetsY Bareche, D Kelly, F Abbas-Aghababazadeh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2016
A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinomaA L Ho, L Dunn, E J Sherman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 17, 2024
Tumor and blood B-cell abundance outperforms established immune checkpoint blockade response prediction signatures in head and neck cancerT-G Chang, A Spathis, A A Schäffer, et al.
Pageof 1